DreamCIS Inc (223250) - Net Assets

Latest as of September 2025: ₩92.81 Billion KRW ≈ $62.90 Million USD

Based on the latest financial reports, DreamCIS Inc (223250) has net assets worth ₩92.81 Billion KRW (≈ $62.90 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩152.85 Billion ≈ $103.58 Million USD) and total liabilities (₩60.03 Billion ≈ $40.68 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check DreamCIS Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩92.81 Billion
% of Total Assets 60.72%
Annual Growth Rate 57.54%
5-Year Change 86.4%
10-Year Change N/A
Growth Volatility 79.07

DreamCIS Inc - Net Assets Trend (2017–2024)

This chart illustrates how DreamCIS Inc's net assets have evolved over time, based on quarterly financial data. Also explore 223250 total assets for the complete picture of this company's asset base.

Annual Net Assets for DreamCIS Inc (2017–2024)

The table below shows the annual net assets of DreamCIS Inc from 2017 to 2024. For live valuation and market cap data, see 223250 stock market capitalisation.

Year Net Assets Change
2024-12-31 ₩67.96 Billion
≈ $46.06 Million
+19.37%
2023-12-31 ₩56.93 Billion
≈ $38.58 Million
+16.29%
2022-12-31 ₩48.96 Billion
≈ $33.18 Million
+28.90%
2021-12-31 ₩37.98 Billion
≈ $25.74 Million
+4.17%
2020-12-31 ₩36.46 Billion
≈ $24.71 Million
+239.20%
2019-12-31 ₩10.75 Billion
≈ $7.28 Million
+65.23%
2018-12-31 ₩6.51 Billion
≈ $4.41 Million
+130.61%
2017-12-31 ₩2.82 Billion
≈ $1.91 Million
--

Equity Component Analysis

This analysis shows how different components contribute to DreamCIS Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6732.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ₩29.74 Billion 43.75%
Common Stock ₩11.90 Billion 17.51%
Other Components ₩26.33 Billion 38.74%
Total Equity ₩67.96 Billion 100.00%

DreamCIS Inc Competitors by Market Cap

The table below lists competitors of DreamCIS Inc ranked by their market capitalization.

Company Market Cap
Graha Layar Prima Tbk
JK:BLTZ
$78.81 Million
Flexible Solutions International Inc
NYSE MKT:FSI
$78.82 Million
Syntec Construction Public Company Limited
BK:SYNTEC
$78.83 Million
PP Presisi Tbk PT
JK:PPRE
$78.84 Million
PT Janu Putra Sejahtera Tbk
JK:AYAM
$78.75 Million
Bhageria Industries Limited
NSE:BHAGERIA
$78.75 Million
DGL Group Ltd
AU:DGL
$78.71 Million
NWF GROUP PLC LS-25
F:NYY
$78.71 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in DreamCIS Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 54,908,597,420 to 67,961,363,600, a change of 13,052,766,180 (23.8%).
  • Net income of 5,280,148,700 contributed positively to equity growth.
  • Share repurchases of 14,289,363,390 reduced equity.
  • New share issuances of 239,313,390 increased equity.
  • Other factors increased equity by 21,822,667,480.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩5.28 Billion +7.77%
Share Repurchases ₩14.29 Billion -21.03%
Share Issuances ₩239.31 Million +0.35%
Other Changes ₩21.82 Billion +32.11%
Total Change ₩- 23.77%

Book Value vs Market Value Analysis

This analysis compares DreamCIS Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.71x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 6.97x to 1.71x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 ₩701.06 ₩4885.00 x
2018-12-31 ₩1616.71 ₩4885.00 x
2019-12-31 ₩2671.35 ₩4885.00 x
2020-12-31 ₩6550.66 ₩4885.00 x
2021-12-31 ₩1739.31 ₩4885.00 x
2022-12-31 ₩2124.13 ₩4885.00 x
2023-12-31 ₩2315.91 ₩4885.00 x
2024-12-31 ₩2855.60 ₩4885.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently DreamCIS Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 7.77%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 9.00%
  • • Asset Turnover: 0.49x
  • • Equity Multiplier: 1.74x
  • Recent ROE (7.77%) is below the historical average (12.11%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 -39.70% -7.02% 1.18x 4.80x ₩-1.40 Billion
2018 52.53% 17.80% 1.09x 2.70x ₩2.77 Billion
2019 38.62% 18.77% 0.88x 2.33x ₩3.08 Billion
2020 13.31% 20.66% 0.48x 1.33x ₩1.21 Billion
2021 8.50% 12.35% 0.46x 1.49x ₩-569.24 Million
2022 9.00% 11.33% 0.50x 1.59x ₩-490.23 Million
2023 6.81% 7.81% 0.54x 1.61x ₩-1.75 Billion
2024 7.77% 9.00% 0.49x 1.74x ₩-1.52 Billion

Industry Comparison

This section compares DreamCIS Inc's net assets metrics with peer companies in the Medical Care Facilities industry.

No peer company data available for comparison.

About DreamCIS Inc

KQ:223250 Korea Medical Care Facilities
Market Cap
$78.79 Million
₩116.26 Billion KRW
Market Cap Rank
#20108 Global
#1157 in Korea
Share Price
₩4885.00
Change (1 day)
-1.31%
52-Week Range
₩2920.00 - ₩7690.00
All Time High
₩8112.50
About

DreamCIS, Inc. operates as a clinical research organization in South Korea. It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headqua… Read more